363-32-6,MFCD09037899
Catalog No.:AA007A1W

363-32-6 | Ethyl 2-fluoro-4-nitrobenzoate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
95+%
in stock  
$58.00   $40.00
- +
1g
98%
in stock  
$70.00   $49.00
- +
5g
98%
in stock  
$167.00   $117.00
- +
25g
98%
in stock  
$582.00 $407.00
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA007A1W
Chemical Name:
Ethyl 2-fluoro-4-nitrobenzoate
CAS Number:
363-32-6
Molecular Formula:
C9H8FNO4
Molecular Weight:
213.1625
MDL Number:
MFCD09037899
SMILES:
CCOC(=O)c1ccc(cc1F)[N+](=O)[O-]
Properties
Computed Properties
 
Complexity:
253  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
3  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
2.1  

Downstream Synthesis Route

[1]Teng;Duong;Klein;Pino;Chandraratna[JournalofMedicinalChemistry,1996,vol.39,#16,p.3035-3038]

[2]CurrentPatentAssignee:ORPHAGENPHARMACEUTICALS-WO2021/127250,2021,A1Locationinpatent:Paragraph0114-0115

[3]CurrentPatentAssignee:ROCHEHOLDINGAG-US2006/276494,2006,A1Locationinpatent:Page/Pagecolumn16

[4]CurrentPatentAssignee:ROCHEHOLDINGAG-US2007/60567,2007,A1Locationinpatent:Page/Pagecolumn21

[5]CurrentPatentAssignee:TOKYOUNIVERSITYOFSCIENCE-JP2020/37518,2020,ALocationinpatent:Paragraph0029;0036

[6]CurrentPatentAssignee:Adams,AlanD.;Huang,ShaeiY.;Szewczyk,JasonW.-US2006/178398,2006,A1Locationinpatent:Page/Pagecolumn29-30

[7]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US5618839,1997,A

[8]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US5648385,1997,A

[9]CurrentPatentAssignee:MERCK&COINC-WO2007/81335,2007,A1Locationinpatent:Page/Pagecolumn47-48

[10]Locationinpatent:experimentalpartRadeke,HeikeS.;Purohit,Ajay;Harris,ThomasD.;Hanson,Kelley;Jones,Reinaldo;Hu,Carol;Yalamanchili,Padmaja;Hayes,Megan;Yu,Ming;Guaraldi,Mary;Kagan,Mikhail;Azure,Michael;Cdebaca,Michael;Robinson,Simon;Casebier,David[ACSMedicinalChemistryLetters,2011,vol.2,#9,p.650-655]

[1]JournalofMedicinalChemistry,1996,vol.39,p.3035-3038

[2]Patent:JP2020/37518,2020,A

[1]Patent:CN107033043,2017,A.Locationinpatent:Paragraph0181;0182;0183

[2]Patent:JP2020/37518,2020,A.Locationinpatent:Paragraph0029;0035

[3]Patent:US2006/276494,2006,A1.Locationinpatent:Page/Pagecolumn16

[4]Patent:US2007/60567,2007,A1.Locationinpatent:Page/Pagecolumn20-21

[5]Patent:US2006/178398,2006,A1.Locationinpatent:Page/Pagecolumn29-30

[6]Patent:WO2007/81335,2007,A1.Locationinpatent:Page/Pagecolumn47-48

[7]ACSMedicinalChemistryLetters,2011,vol.2,p.650-655

Na2Cr2O7 
  7664-93-9    1427-07-2    363-32-6 

[1]Patent:US5965606,1999,A

[2]Patent:US5663357,1997,A

[3]Patent:US5675024,1997,A

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 363-32-6
Tags:363-32-6 Molecular Formula|363-32-6 MDL|363-32-6 SMILES|363-32-6 Ethyl 2-fluoro-4-nitrobenzoate
Catalog No.: AA007A1W
363-32-6,MFCD09037899
363-32-6 | Ethyl 2-fluoro-4-nitrobenzoate
Pack Size: 250mg
Purity: 95+%
in stock
$58.00 $40.00
Pack Size: 1g
Purity: 98%
in stock
$70.00 $49.00
Pack Size: 5g
Purity: 98%
in stock
$167.00 $117.00
Pack Size: 25g
Purity: 98%
in stock
$582.00 $407.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA007A1W
Chemical Name: Ethyl 2-fluoro-4-nitrobenzoate
CAS Number: 363-32-6
Molecular Formula: C9H8FNO4
Molecular Weight: 213.1625
MDL Number: MFCD09037899
SMILES: CCOC(=O)c1ccc(cc1F)[N+](=O)[O-]
Properties
Complexity: 253  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 15  
Hydrogen Bond Acceptor Count: 5  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 3  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 2.1  
Downstream Synthesis Route
363-32-6    73792-06-0 

[1]Teng;Duong;Klein;Pino;Chandraratna[JournalofMedicinalChemistry,1996,vol.39,#16,p.3035-3038]

[2]CurrentPatentAssignee:ORPHAGENPHARMACEUTICALS-WO2021/127250,2021,A1Locationinpatent:Paragraph0114-0115

[3]CurrentPatentAssignee:ROCHEHOLDINGAG-US2006/276494,2006,A1Locationinpatent:Page/Pagecolumn16

[4]CurrentPatentAssignee:ROCHEHOLDINGAG-US2007/60567,2007,A1Locationinpatent:Page/Pagecolumn21

[5]CurrentPatentAssignee:TOKYOUNIVERSITYOFSCIENCE-JP2020/37518,2020,ALocationinpatent:Paragraph0029;0036

[6]CurrentPatentAssignee:Adams,AlanD.;Huang,ShaeiY.;Szewczyk,JasonW.-US2006/178398,2006,A1Locationinpatent:Page/Pagecolumn29-30

[7]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US5618839,1997,A

[8]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US5648385,1997,A

[9]CurrentPatentAssignee:MERCK&COINC-WO2007/81335,2007,A1Locationinpatent:Page/Pagecolumn47-48

[10]Locationinpatent:experimentalpartRadeke,HeikeS.;Purohit,Ajay;Harris,ThomasD.;Hanson,Kelley;Jones,Reinaldo;Hu,Carol;Yalamanchili,Padmaja;Hayes,Megan;Yu,Ming;Guaraldi,Mary;Kagan,Mikhail;Azure,Michael;Cdebaca,Michael;Robinson,Simon;Casebier,David[ACSMedicinalChemistryLetters,2011,vol.2,#9,p.650-655]

1427-07-2    363-32-6 

[1]JournalofMedicinalChemistry,1996,vol.39,p.3035-3038

[2]Patent:JP2020/37518,2020,A

64-17-5    403-24-7    363-32-6 

[1]Patent:CN107033043,2017,A.Locationinpatent:Paragraph0181;0182;0183

[2]Patent:JP2020/37518,2020,A.Locationinpatent:Paragraph0029;0035

[3]Patent:US2006/276494,2006,A1.Locationinpatent:Page/Pagecolumn16

[4]Patent:US2007/60567,2007,A1.Locationinpatent:Page/Pagecolumn20-21

[5]Patent:US2006/178398,2006,A1.Locationinpatent:Page/Pagecolumn29-30

[6]Patent:WO2007/81335,2007,A1.Locationinpatent:Page/Pagecolumn47-48

[7]ACSMedicinalChemistryLetters,2011,vol.2,p.650-655

Na2Cr2O7 
  7664-93-9    1427-07-2    363-32-6 

[1]Patent:US5965606,1999,A

[2]Patent:US5663357,1997,A

[3]Patent:US5675024,1997,A

Building Blocks More >
1693-37-4
1693-37-4
N-(4-Hydroxyphenyl)propanamide
AA007AJV | MFCD00791257
1070879-22-9
1070879-22-9
Methyl 2-((benzyloxycarbonylamino)methyl)-1h-imidazole-5-carboxylate
AA007B3N | MFCD11052867
1068162-79-7
1068162-79-7
2-Chloro-4-(3-chloro-4-cyanophenyl)benzonitrile
AA007BNO | MFCD21609603
37052-78-1
37052-78-1
5-Methoxy-2-mercaptobenzimidazole
AA007C98 | MFCD00134581
35965-96-9
35965-96-9
4-(2-Phenoxyethoxy)aniline
AA007CUI | MFCD00025327
1670-85-5
1670-85-5
1H-Indole-3-carboxylic acid amide
AA007DDI | MFCD00460642
1060817-72-2
1060817-72-2
N-Methyl-1-(4-methyl-1,2,3-thiadiazol-5-yl)methanamine
AA007E1N | MFCD11054019
1073353-44-2
1073353-44-2
3-Chloromethylphenylboronic acid pinacol ester
AA007EKX | MFCD11053847
1040276-87-6
1040276-87-6
1-BOC-4-bromo-3,5-dimethylpyrazole
AA007F1M | MFCD12756451
10510-77-7
10510-77-7
5-Ethylphenazin-5-ium ethyl sulfate
AA007FKQ | MFCD00050286
Submit
© 2017 AA BLOCKS, INC. All rights reserved.